Author: Casucci, Gerardo; Acanfora, Domenico
Title: DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination Cord-id: hprry4kl Document date: 2021_6_1
ID: hprry4kl
Snippet: In recent weeks, adverse reactions have been reported after administration of Oxford–AstraZeneca chimpanzee adenovirus vectored vaccine ChAdOx1 nCoV-19 (AZD1222), in particular thrombus formation, which has led several European Countries to discontinue administration of this vaccine. On March 8, 2021, the European Medicines Agency Safety Committee did not confirm this probable association. We report the case of a patient who developed disseminated intravascular coagulation after the first dose
Document: In recent weeks, adverse reactions have been reported after administration of Oxford–AstraZeneca chimpanzee adenovirus vectored vaccine ChAdOx1 nCoV-19 (AZD1222), in particular thrombus formation, which has led several European Countries to discontinue administration of this vaccine. On March 8, 2021, the European Medicines Agency Safety Committee did not confirm this probable association. We report the case of a patient who developed disseminated intravascular coagulation after the first dose of Oxford-Astra Zeneca vaccine, which resolved in a few days with the administration of dexamethasone and enoxaparin. This work demonstrates the safety of the Oxford-Astra Zeneca vaccine and that any development of side effects can be easily managed with a prompt diagnosis and in a short time with a few commonly used drugs.
Search related documents:
Co phrase search for related documents- abdominal ultrasound and acute respiratory distress syndrome: 1, 2, 3
- acquire syndrome and acute respiratory: 1, 2, 3, 4, 5
- acquire syndrome and acute respiratory distress syndrome: 1
- acute respiratory and adenoviral vector: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute respiratory and adenoviral vector chadox1: 1
- acute respiratory and adenovirus vaccine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
- acute respiratory and adenovirus vaccine platform: 1
- acute respiratory and low age decrease: 1
- acute respiratory distress syndrome and adenoviral vector: 1, 2
Co phrase search for related documents, hyperlinks ordered by date